Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0000903423-17-000618

Options or other derivatives

  • 10% owner bought 500,000 shares at $100.00 ($50,000,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
VIKING GLOBAL PERFORMANCE LLC 10% owner 2017-10-16 Purchase · Series A Participating Convertible Preferred Shares +500,000 $100.00 $50,000,000 500,000 I
Loading xslF345X03/vikingf4aurbtusfirstt.xml…